BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 16181053)

  • 1. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
    Zhu H; Nelson DR; Crawford JM; Liu C
    J Interferon Cytokine Res; 2005 Sep; 25(9):528-39. PubMed ID: 16181053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 induces anti-hepatitis C viral activity in liver cells.
    Zhu H; Shang X; Terada N; Liu C
    Biochem Biophys Res Commun; 2004 Nov; 324(2):518-28. PubMed ID: 15474458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
    Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
    Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
    Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
    Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C.
    Huang Y; Feld JJ; Sapp RK; Nanda S; Lin JH; Blatt LM; Fried MW; Murthy K; Liang TJ
    Gastroenterology; 2007 Feb; 132(2):733-44. PubMed ID: 17258724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha antagonizes STAT3 and SOCS3 signaling triggered by hepatitis C virus.
    Zhao LJ; He SF; Wang W; Ren H; Qi ZT
    Cytokine; 2016 Apr; 80():48-55. PubMed ID: 26945996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation.
    Fimia GM; Evangelisti C; Alonzi T; Romani M; Fratini F; Paonessa G; Ippolito G; Tripodi M; Piacentini M
    J Virol; 2004 Dec; 78(23):12809-16. PubMed ID: 15542633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon-gamma stimuli.
    Hosui A; Ohkawa K; Ishida H; Sato A; Nakanishi F; Ueda K; Takehara T; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Biol Chem; 2003 Aug; 278(31):28562-71. PubMed ID: 12764155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha.
    Lupberger J; Duong FH; Fofana I; Zona L; Xiao F; Thumann C; Durand SC; Pessaux P; Zeisel MB; Heim MH; Baumert TF
    Hepatology; 2013 Oct; 58(4):1225-35. PubMed ID: 23519785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway.
    Heim MH; Moradpour D; Blum HE
    J Virol; 1999 Oct; 73(10):8469-75. PubMed ID: 10482599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice.
    Blindenbacher A; Duong FH; Hunziker L; Stutvoet ST; Wang X; Terracciano L; Moradpour D; Blum HE; Alonzi T; Tripodi M; La Monica N; Heim MH
    Gastroenterology; 2003 May; 124(5):1465-75. PubMed ID: 12730885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
    Poat B; Hazari S; Chandra PK; Gunduz F; Balart LA; Alvarez X; Dash S
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20949125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.
    Song MM; Shuai K
    J Biol Chem; 1998 Dec; 273(52):35056-62. PubMed ID: 9857039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
    Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
    J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
    Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
    Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.
    Frese M; Pietschmann T; Moradpour D; Haller O; Bartenschlager R
    J Gen Virol; 2001 Apr; 82(Pt 4):723-733. PubMed ID: 11257176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.